|
1
|
Kew MC: Epidemiology of chronic hepatitis
B virus infection, hepatocellular carcinoma, and hepatitis B
virus-induced hepatocellular carcinoma. Pathol Biol (Paris).
58:273–277. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sherman M: Hepatocellular carcinoma: New
and emerging risks. Dig Liver Dis. 42 Suppl 3:S215–S222. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dragani TA: Risk of HCC: Genetic
heterogeneity and complex genetics. J Hepatol. 52:252–257. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Feo F, De Miglio MR, Simile MM, Muroni MR,
Calvisi DF, Frau M and Pascale RM: Hepatocellular carcinoma as a
complex polygenic disease. Interpretive analysis of recent
developments on genetic predisposition. Biochim Biophys Acta.
1765:126–147. 2006.PubMed/NCBI
|
|
5
|
Rajendiran S, Parwani AV, Hare RJ,
Dasgupta S, Roby RK and Vishwanatha JK: MicroRNA-940 suppresses
prostate cancer migration and invasion by regulating MIEN1. Mol
Cancer. 13:2502014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calin GA, Liu CG, Sevignani C, Ferracin M,
Felli N, Dumitru CD, Shimizu M, Cimmino A, Zupo S, Dono M, et al:
MicroRNA profiling reveals distinct signatures in B cell chronic
lymphocytic leukemias. Proc Natl Acad Sci USA. 101:11755–11760.
2004; View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ventura A and Jacks T: MicroRNAs and
cancer: Short RNAs go a long way. Cell. 136:586–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wiemer EA: The role of microRNAs in
cancer: No small matter. Eur J Cancer. 43:1529–1544. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z,
Zhan Q, Deng X, Chen H, Shen B, et al: miR-150-5p Inhibits Hepatoma
cell migration and invasion by targeting MMP14. PLoS One.
9:e1155772014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang XP, Hou J, Shen XY, Huang CY, Zhang
XH, Xie YA and Luo XL: MicroRNA-486-5p, which is downregulated in
hepatocellular carcinoma, suppresses tumor growth by targeting
PIK3R1. FEBS J. 282:579–594. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kerr TA, Korenblat KM and Davidson NO:
MicroRNAs and liver disease. Transl Res. 157:241–252. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang S and He X: The role of microRNAs in
liver cancer progression. Br J Cancer. 104:235–240. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Di Leva G and Croce CM: miRNA profiling of
cancer. Curr Opin Genet Dev. 23:3–11. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shih TC, Tien YJ, Wen CJ, Yeh TS, Yu MC,
Huang CH, Lee YS, Yen TC and Hsieh SY: MicroRNA-214 downregulation
contributes to tumor angiogenesis by inducing secretion of the
hepatoma-derived growth factor in human hepatoma. J Hepatol.
57:584–591. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zeng XC, Liu FQ, Yan R, Yi HM, Zhang T,
Wang GY, Li Y and Jiang N: Downregulation of miR-610 promotes
proliferation and tumorigenicity and activates Wnt/β-catenin
signaling in human hepatocellular carcinoma. Mol Cancer.
13:2612014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Reya T and Clevers H: Wnt signalling in
stem cells and cancer. Nature. 434:843–850. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gheinani A Hashemi, Burkhard FC, Rehrauer
H, Fournier C Aquino and Monastyrskaya K: MicroRNA miR-199a-5p
regulates smooth muscle cell proliferation and morphology by
targeting Wnt2 signaling pathway. J Biol Chem. 13:7067–7086. 2015.
View Article : Google Scholar
|
|
19
|
Qu B, Liu BR, Du YJ, Chen J, Cheng YQ, Xu
W and Wang XH: Wnt/β-catenin signaling pathway may regulate the
expression of angiogenic growth factors in hepatocellular
carcinoma. Oncol Lett. 7:1175–1178. 2014.PubMed/NCBI
|
|
20
|
de La Coste A, Romagnolo B, Billuart P,
Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C,
Kahn A and Perret C: Somatic mutations of the beta-catenin gene are
frequent in mouse and human hepatocellular carcinomas. Proc Natl
Acad Sci USA. 95:8847–8851. 1998; View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Miyoshi Y, Iwao K, Nagasawa Y, Aihara T,
Sasaki Y, Imaoka S, Murata M, Shimano T and Nakamura Y: Activation
of the beta-catenin gene in primary hepatocellular carcinomas by
somatic alterations involving exon 3. Cancer Res. 58:2524–2527.
1998.PubMed/NCBI
|
|
22
|
Shi X and Garry DJ: Muscle stem cells in
development, regeneration, and disease. Genes Dev. 20:1692–1708.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tanaka S, Terada K and Nohno T: Canonical
Wnt signaling is involved in switching from cell proliferation to
myogenic differentiation of mouse myoblast cells. J Mol Signal.
6:122011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Anastas JN and Moon RT: WNT signalling
pathways as therapeutic targets in cancer. Nat Rev Cancer.
13:11–26. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li D, Liu W, Wang X, Wu J, Quan W, Yao Y,
Bals R, Ji S, Wu K, Guo J and Wan H: Cathelicidin, an antimicrobial
peptide produced by macrophages, promotes colon cancer by
activating the Wnt/β-catenin pathway. Oncotarget. 6:2939–2950.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gougelet A and Colnot S: A complex
interplay between Wnt/β-catenin signalling and the cell cycle in
the adult liver. Int J Hepatol. 2012:8161252012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
He TC, Sparks AB, Rago C, Hermeking H,
Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW:
Identification of c-MYC as a target of the APC pathway. Science.
281:1509–1512. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Constantinou T, Baumann F, Lacher MD,
Saurer S, Friis R and Dharmarajan A: SFRP-4 abrogates
Wnt-3a-induced beta-catenin and Akt/PKB signalling and reverses a
Wnt-3a-imposed inhibition of in vitro mammary differentiation. J
Mol Signal. 3:102008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pan LH, Yao M, Cai Y, Gu JJ, Yang XL, Wang
L and Yao DF: Oncogenic Wnt3a expression as an estimable prognostic
marker for hepatocellular carcinoma. World J Gastroenterol.
22:3829–3836. 2016. View Article : Google Scholar : PubMed/NCBI
|
